Basheerahmed Abdulaziz Mannasaheb

Mr. Basheerahmed Abdulaziz Mannasaheb

Pharmacy Practice, AlMaarefa University, Riyadh, Ar Riyāḑ, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2022 in Molecules
Verified
Journal Article
Open access
PDF file
UMUday M Muddapur
Uday M Muddapur
SASultan Alshehri
Sultan Alshehri
MGMohammed M. Ghoneim
Mohammed M. Ghoneim
MMMater H. Mahnashi
Mater H. Mahnashi
MAMohammed Abdulrahman Alshahrani
Mohammed Abdulrahman Alshahrani
Mohammad Zaki AhmadMohammad Zaki Ahmad
Mohammad Zaki Ahmad
Bionanotechnology is a branch of science that has revolutionized modern science and technology. Nanomaterials, especially noble metals, have attracted researchers due to their size and application in different branches of sciences that benefit humanity. Metal nanoparticles can be synthesized using green methods, which are good for the environment, economically viable, and facilitate synthesis. Due to their size and form, gold nanoparticles have become significant. Plant materials are of particular interest in the synthesis and manufacture of theranostic gold nanoparticles (NPs), which have been generated using various materials. On the other hand, chemically produced nanoparticles have several drawbacks in terms of cost, toxicity, and effectiveness. A plant-mediated integration of metallic nanoparticles has been developed in the field of nanotechnology to overcome the drawbacks of traditional synthesis, such as physical and synthetic strategies. Nanomaterials′ tunable features make them sophisticated tools in the biomedical platform, especially for developing new diagnostics and therapeutics for malignancy, neurodegenerative, and other chronic disorders. Therefore, this review outlines the theranostic approach, the different plant materials utilized in theranostic applications, and future directions based on current breakthroughs in these fields.

22 April 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Ibrahim Ahmed ShaikhIbrahim Ahmed Shaikh
Ibrahim Ahmed Shaikh
UMUday M Muddapur
Uday M Muddapur
ZBZabin K. Bagewadi
Zabin K. Bagewadi
SCSneha Chiniwal
Sneha Chiniwal
MGMohammed M. Ghoneim
Mohammed M. Ghoneim
SISyed Mohammad Shakeel Iqubal
Syed Mohammad Shakeel Iqubal
The applications of bioactive compounds from medicinal plants as therapeutic drugs are largely increasing. The present study selected the bioactive compounds from Acacia concinna (A. concinna) and Citrus limon (C. limon) to assess their phytochemicals, proteins, and biological activity. The plant material was collected, and extraction performed as per the standard procedure. Qualitative analysis was undertaken, and identification of functional organic groups was performed by FTIR and HPLC. Antibacterial, anticancer, antioxidant, antihyperglycemic, antihyperlipidemic, and inhibition kinetics studies for enzymes were performed to assess the different biological activities. Flavonoids and phenols were present in a significant amount in both the selected plants. A. concinna showed significant antimicrobial activity against Z. mobilis, E. coli, and S. aureus, with minimum inhibition zones (MIZ) of 24, 22, and 20 mm, respectively. C. limon strongly inhibited all the tested pathogenic bacteria with maximum and minimum MIZ of 32 and 17 mm. A. concinna silver nanoparticles also exhibited potent antimicrobial activity. Both extracts showed substantial antioxidant, antihyperlipidemic, antidiabetic, anticancer (MCF-7), and anti-urease (antiulcer) properties. To conclude, these plants can be used to treat hyperlipidemia, diabetes, cancer, and gastrointestinal ulcers. They can also serve as antimicrobial and antioxidant agents. Thus, the studied plants must be exploited cost-effectively to generate therapeutic drugs for various diseases.

1 February 2022 in Risk Management and Healthcare Policy
Verified
Journal Article
Open access
PDF file
AAAwad Mohammed Al-Qahtani
Awad Mohammed Al-Qahtani
Ibrahim Ahmed ShaikhIbrahim Ahmed Shaikh
Ibrahim Ahmed Shaikh
MSMohammed Ashique K Shaikh
Mohammed Ashique K Shaikh
BMBasheerahmed Abdulaziz Mannasaheb
Basheerahmed Abdulaziz Mannasaheb
FAFaisal Saeed Al-Qahtani
Faisal Saeed Al-Qahtani
Background: Self-medication (SM) is a customary practice around the globe. Appropriate SM comes with many advantages, yet irrational SM is a concern and could lead to adverse drug events and poor health outcomes. Methods: This college-based cross-sectional study was carried out from January to March 2021 among Najran University undergraduate medical students to investigate the prevalence and practice of, and attitudes towards SM. Data were collected using a bilingual self-administered online questionnaire, which was categorized into sections, such as socio-demographic details, attitude towards SM, and practice of SM during the last six months, along with students’ opinions and suggestions regarding SM. The three-item scale was used to assess the students’ attitude. IBM SPSS was used to perform the cross-tabulation, chi-squared test, and binary logistic regression. Results: Overall, 205 undergraduate medical students (58.6%) responded to the survey. The overall prevalence of SM was 60%, of which 25% used antibiotics as SM drugs. Headache (65.9%), fever (30.2%), cold/flu (31.2%), and gastric acidity (28.3%) were common illnesses for which SM was sought, using analgesics and NSAIDs (52.7%), antipyretics (13.7%), and antacid (12.7%) medications. Among the reasons for SM, the illness being minor and quick relief were frequently reported. To rationalize and improve the practice of SM, about half (48.3%) of the students suggested spreading awareness and education regarding the implications of SM and dispensing the medications with prescriptions (46.8%). Conclusion: Overall, the attitude towards SM was satisfactory. The prevalence of SM during the last six months was 60%, and antibiotics were used by 25% of students. A significant negative correlation was observed between attitudes towards and practice of SM. Although medical students of Najran University displayed responsible behavior towards SM, efforts should be made to educate them about the adverse consequences of SM, especially with antibiotics.

19 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
AAAdel Alghamdi
Adel Alghamdi
MAMansour Almuqbil
Mansour Almuqbil
MAMohammad A. Alrofaidi
Mohammad A. Alrofaidi
ABAbdulhadi Burzangi
Abdulhadi Burzangi
AAAli A. Alshamrani
Ali A. Alshamrani
SASyed Mohammed Basheeruddin Asdaq
Syed Mohammed Basheeruddin Asdaq
This study aimed to examine the antidepressant properties of apigenin in an experimental mouse model of chronic mild stress (CMS). Three weeks following CMS, albino mice of either sex were tested for their antidepressant effects using the tail suspension test (TST) and the sucrose preference test. The percentage preference for sucrose solution and the amount of time spent immobile in the TST were calculated. The brain malondialdehyde (MDA) levels, catalase activity, and reduced glutathione levels were checked to determine the antioxidant potential of treatments. When compared to the control, animals treated with apigenin during the CMS periods showed significantly shorter TST immobility times. Apigenin administration raised the percentage preference for sucrose solution in a dose-dependent manner, which put it on par with the widely used antidepressant imipramine. Animals treated with apigenin displayed a significantly (p ˂ 0.05) greater spontaneous locomotor count (281) when compared to the vehicle-treated group (245). Apigenin was also highly effective in significantly (p ˂ 0.01) lowering plasma corticosterone levels (17 vs. 28 µg/mL) and nitrite (19 vs. 33 µg/mL) produced by CMS in comparison to the control group. During CMS, a high dose (50 mg/kg) of apigenin was given, which greatly increased the reduced glutathione level while significantly decreasing the brain’s MDA and catalase activity when compared to the control group. As a result, we infer that high doses of apigenin may have potential antidepressant effects in animal models via various mechanisms.

6 September 2023 in Saudi Journal of Biological Sciences
Verified
Journal Article
Open access
ARArchana G. Revankar
Archana G. Revankar
ZBZabin K. Bagewadi
Zabin K. Bagewadi
Ibrahim Ahmed ShaikhIbrahim Ahmed Shaikh
Ibrahim Ahmed Shaikh
BMBasheerahmed Abdulaziz Mannasaheb
Basheerahmed Abdulaziz Mannasaheb
MGMohammed M. Ghoneim
Mohammed M. Ghoneim
SASyed Mohammed Basheeruddin Asdaq
Syed Mohammed Basheeruddin Asdaq
Cyclooxygenase 2 (COX-2) participates in the inflammation process by converting arachidonic acid into prostaglandin G2 which increases inflammation, pain and fever. COX-2 has an active site and a heme pocket and blocking these sites stops the inflammation. Urolithin A is metabolite of ellagitannin produced from humans and animals gut microbes. In the current study, Urolithin A showed good pharmacokinetic properties. Molecular docking of the complex of Urolithin A and COX-2 revealed the ligand affinity of −7.97 kcal/mol with the ligand binding sites at TYR355, PHE518, ILE517 and GLN192 with the 4-H bonds at a distance of 2.8 Å, 2.3 Å, 2.5 Å and 1.9 Å. The RMSD plot for Urolithin A and COX-2 complex was observed to be constant throughout the duration of dynamics. A total of 3 pair of hydrogen bonds was largely observed on average of 3 simulation positions for dynamics duration of 500 ns. The MMPBSA analysis showed that active site amino acids had a binding energy of –22.0368 kJ/mol indicating that throughout the simulation the protein of target was bounded by Urolithin A. In-silico results were validated by biological assays. Urolithin A strongly revealed to exhibit anti-inflammatory effect on COX-2 with an IC50 value of 44.04 µg/mL. The anti-inflammatory capability was also depicted through reduction of protein denaturation that showed 37.6 ± 0.1 % and 43.2 ± 0.07 % reduction of protein denaturation for BSA and egg albumin respectively at 500 µg/mL. The present study, suggests Urolithin A to be an effective anti-inflammatory compound for therapeutic use.

25 March 2022 in Frontiers in Public Health
Verified
Journal Article
Open access
BMBasheerahmed Abdulaziz Mannasaheb
Basheerahmed Abdulaziz Mannasaheb
SASarah Abdulrahman Alajlan
Sarah Abdulrahman Alajlan
JAJaber Abdullah Alshahrani
Jaber Abdullah Alshahrani
NONoordin Othman
Noordin Othman
SASultan Othman Alolayan
Sultan Othman Alolayan
MAMohammed Alasmary
Mohammed Alasmary
Irrational Self-Medication (SM) practice leads to incorrect diagnosis and is a risk factor for disease exacerbation and serious health consequences. Hence Responsible SM is vital for better health outcomes. In the present community-based study we explored the SM practice during the last 3 months, frequency, outcome, medications used, reasons influencing SM, source of the drug, and information. Data were analyzed using SPSS; chi-square test was performed to indicate significance, Odds ratio, Pearson correlation, univariant and multivariant regression analysis were performed to find out factors and predictors of SM. A total of 611 residents completed the survey. SM was practiced by 52.9% of participants during the last 3 months, with a frequency of one to two times. Headache (64.8%), pain (35.4%), fever/flu (31.4%), cold & cough (21.9%) and dysmenorrhea (20.9%) were illnesses managed using pain killers (75.9%), multivitamins (25.5%), anti-pyretic (24.7%) and herbal medicines (18.5%). Minor illness (67.9%), earlier experience (33.9%) and shortness of time to attend healthcare facilities (18.8%) were the reasons for practicing SM. Distance to healthcare and routine physical activity have significantly influenced the SM practice. Residents stated that inappropriate SM would lead to negative outcomes, including drug side effects (70%), Interaction (34.2%), poor treatment outcome (32.6%) and return of symptoms (26.5%). Interestingly, two-thirds of participants (68.9%) have recommended SM in case of minor illnesses only, 85.3% of respondents have expressed their desire to learn more about appropriate SM, and 76.6% are willing to return their leftover or unused medications to drug take-back centers.